My Cart

[HLA-A*1101 & B2M & KRASG12C (VVVGACGVGK)

Product Inquiry

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
HB-0056HB-0056; HB0056Phase 1 ClinicalShanghai Huaota Biopharmaceutical Co LtdAsthma
Details
9MW38119MW3811Phase 1 ClinicalMabwell (Shanghai) Bioscience Co LtdSolid tumours; Idiopathic Pulmonary Fibrosis; Neoplasms; Fibrosis; Pulmonary Fibrosis
Details
LASN-03Lassen Therapeutics
Details

Marketed Drug Information

English NameResearch CodeHighest Development StageCompanyFirst Brand NameFirst Approved CountryFirst IndicationFirst Approved CompanyFirst Approved DateIndicationClinical Trial
Recombinant human interleukin-11 (Hangzhou Jiuyuan Gene Engineering Co Ltd )ApprovedThrombocytopenia
Details
  • Product Inquiry
  • Marketed Drug Information
  • Clinical Drug Information
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland